🔗 Share this article

A shadow market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Drug Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles directly for source information, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could lead to users injecting substances of uncertain source.

Some experts said the popularity for the experimental drug could be connected to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and customer regulations, risking fines, legal action or prison.

Service Response and Content Elimination

Based on the social media company, the service has removed problematic content and prohibited related keywords and search suggestions. The company stated it was committed to keeping the platform secure and allocating resources in enhancing compliance measures.

Digital Marketplace Operations

Research also discovered groups with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step guides for preparing or injecting at residence.

After minutes of entering one group, a seller shared contact information, where the majority of transactions occur. The vendor sent an instruction manual and promised shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about weight, medical conditions or past usage.

Product Information and Costs

Inside these communities, messages show black plastic parcels with Royal Mail stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When asked how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service said it actively moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they can’t verify. Although the research behind this drug is sound, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has already seen individuals harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet authorized … may subject users to potentially significant medical dangers”.